Skip to content

Clinical trials

Phase 2 Autoimmune Diseases trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Autoimmune Diseases Phase: Phase 2 Country / region: United States Clear all

74 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20022
20031
20041
20055
20064
20071
20083
20103
20115
20121
20131
20151
20162
20171
20182
20193
20206
20214
20223
20233
20242
20257
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed37
Recruiting12
Terminated12
Active, not recruiting10
Unknown status3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Heart, Lung, and Blood Institute (NHLBI)8
National Cancer Institute (NCI)6
National Institute of Allergy and Infectious Diseases (NIAID)4
Novartis Pharmaceuticals4
Immunovant Sciences GmbH3
National Institute of Dental and Craniofacial Research (NIDCR)3
Anthera Pharmaceuticals2
Eli Lilly and Company2
Fred Hutchinson Cancer Center2
Northwestern University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Autoimmune Diseases74
Immune System Diseases17
Lupus Erythematosus, Systemic12
Sjogren's Syndrome8
Thrombocytopenia8
Anemia, Aplastic7
Arthritis, Rheumatoid6
Skin Diseases6
Connective Tissue Diseases5
Inflammation5

Trials

Showing 1 to 25 of 74. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.